(Q31389226)

1 July 2017

title

Enhanced tryptophan degradation in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

1 July 2017

main subject

1 reference

Gabriele Baier-Bitterlich

inferred from title

author

7

object named as

Baier-Bitterlich G

1 reference

1 July 2017

Widner B

1

1 reference

1 July 2017

Sepp N

2

1 reference

1 July 2017

Kowald E

3

1 reference

1 July 2017

Ortner U

4

1 reference

1 July 2017

Wirleitner B

5

1 reference

1 July 2017

Fritsch P

6

1 reference

1 July 2017

Fuchs D

8

1 reference

1 July 2017

publication date

1 April 2000

1 reference

1 July 2017

1 reference

1 July 2017

volume

201

1 reference

1 July 2017

issue

5

1 reference

1 July 2017

page(s)

621-630

1 reference

Lupus: Key Pathogenic Mechanisms and Contributing Factors

1 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Histone mediates glomerular deposition of small size DNA anti-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Skeletal muscle immune deposits in systemic lupus erythematosus. Correlation with histologic changes, autoantibodies, and clinical involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Cytokine abnormalities in human lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Neopterin as a marker for activated cell-mediated immunity: application in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Induction of pulmonary indoleamine 2,3-dioxygenase by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Activated immune system in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Serum kynurenine and neopterin concentrations in patients with cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Much IDO about pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

L-Tryptophan in Neuropsychiatry Disorders: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Rapid depletion of plasma tryptophan: a review of studies and experimental methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Kynurenine metabolites of tryptophan: implications for neurologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2800%2980079-0

7 January 2021

10.1016/S0171-2985(00)80079-0

Identifiers

DOI

0 references

1 reference